ESCRS - FP32.04 - An Extended-Depth Of Focus Iol Visual Disturbances Outcomes Implanted In Patients With Dry Eye

An Extended-Depth Of Focus Iol Visual Disturbances Outcomes Implanted In Patients With Dry Eye

Published 2023 - 41st Congress of the ESCRS

Reference: FP32.04 | Type: Free paper | DOI: 10.82333/2160-4t51

Authors: Fernando Llovet Osuna* 1 , Caridad Perez-Vives 2

1Cataract and Refractive Surgery,Clinica Baviera - AIER EYE Group,Madrid,Spain, 2Alcon Vision,Alcon,Barcelona,Spain

Purpose

To evaluate visual performance and patient reported outcomes in subjects with previous dry eye implanted bilaterally with AcrySof IQ Vivity or/and AcrySof IQ Vivity Toric IOL.

Setting

Sub-group analysis of a multicenter, ambispective registry study conducted in Europe, Australia and New Zealand evaluating the performance of subjects with previous dry eye and bilaterally implanted with AcrySof IQ Vivity and/or AcrySof IQ Vivity Toric IOL in a real world setting through routine clinical practice.

Methods

At the study entry visit, between 3-6 months after the 2nd eye surgery, binocular uncorrected and distance corrected visual acuities at distance, intermediate (66 cm) and near (40 cm) were measured (UCDVA/BCDVA, UCIVA/DCIVA and UCNVA/DCNVA). Patient reported outcomes were also evaluated through validated questionnaires, such as Catquest SF-9 for patient’s satisfaction and IOLSAT for spectacle independence. Visual disturbances were also evaluated through a non-prompted interview.

Results

This final analysis includes 85 subjects (9.3% of the overall study population) diagnosed with dry eye and bilaterally implanted with AcrySof IQ Vivity IOL. At study entry visit binocular mean logMAR (SD) UCDVA, UCIVA and UCNVA were 0.019 (0.113), 0.085 (0.131) and 0.231 (0.151), respectively. Binocular mean logMAR (SD) BCDVA, DCIVA and DCNVA were -0.025 (0.080), 0.093 (0.131) and 0.261 (0.140), respectively. The majority of the subjects reported never using spectacles for far away (88%) and arm’s length (74.1%). High levels of satisfaction were observed, with 80% of subjects reporting that they were satisfied with their sight. In addition, no halos, glare or starbursts were reported by 90.6%, 92.9% and 89.4% of subjects, respectively.

Conclusions

In this study, subjects with dry eye bilaterally implanted with DFT015 or DFTX15-Toric IOLs achieved good distance, intermediate and functional near vision. Subjects in this subgroup also reported good levels of spectacle independence, high levels of satisfaction with their vision, and low levels of visual disturbances.